GERM vs. SURI ETF Comparison
Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI)
GERM
ETFMG Treatments Testing and Advancements ETF
GERM Description
GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.
Grade (RS Rating)
Last Trade
$18.07
Average Daily Volume
1,678
Number of Holdings
*
48
* may have additional holdings in another (foreign) market
SURI
Simplify Exchange Traded Funds Simplify Propel Opportunities ETF
SURI Description
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.Grade (RS Rating)
Last Trade
$22.59
Average Daily Volume
20,035
Number of Holdings
*
10
* may have additional holdings in another (foreign) market
Performance
| Period | GERM | SURI |
|---|---|---|
| 30 Days | 0.88% | -7.07% |
| 60 Days | -2.09% | -11.34% |
| 90 Days | -2.82% | 8.93% |
| 12 Months | -16.72% | 8.91% |
0 Overlapping Holdings
| Symbol | Grade | Weight in GERM | Weight in SURI | Overlap |
|---|
GERM Overweight 48 Positions Relative to SURI
| Symbol | Grade | Weight | |
|---|---|---|---|
| MRNA | B | 7.48% | |
| DGX | B | 6.82% | |
| BNTX | D | 6.26% | |
| ALNY | D | 6.15% | |
| LH | F | 5.78% | |
| DVAX | D | 3.7% | |
| IMCR | C | 3.63% | |
| PCVX | C | 3.56% | |
| BIO | F | 3.47% | |
| ZLAB | F | 3.13% | |
| VIR | F | 2.87% | |
| OPK | D | 2.38% | |
| BCRX | D | 2.29% | |
| ARCT | F | 1.81% | |
| SIGA | C | 1.61% | |
| NVAX | F | 1.59% | |
| HLVX | F | 1.59% | |
| FLGT | F | 1.49% | |
| CVAC | F | 1.44% | |
| ABUS | B | 1.1% | |
| AZN | A | 1.02% | |
| ADPT | D | 0.98% | |
| OSUR | F | 0.95% | |
| ALT | D | 0.92% | |
| SNY | B | 0.9% | |
| LLY | C | 0.89% | |
| PFE | D | 0.88% | |
| OCGN | B | 0.87% | |
| MRK | B | 0.87% | |
| GSK | A | 0.87% | |
| REGN | C | 0.81% | |
| JNJ | F | 0.8% | |
| ABBV | D | 0.79% | |
| TAK | F | 0.78% | |
| GILD | F | 0.78% | |
| ABT | F | 0.77% | |
| CRMD | B | 0.73% | |
| ENTA | D | 0.69% | |
| XBIT | B | 0.6% | |
| RENB | F | 0.51% | |
| VXRT | F | 0.29% | |
| EBS | C | 0.24% | |
| CUE | D | 0.21% | |
| IFRX | F | 0.2% | |
| GRTS | F | 0.2% | |
| CMRX | F | 0.2% | |
| CVM | F | 0.19% | |
| VAXX | F | 0.04% |
GERM: Top Represented Industries & Keywords
SURI: Top Represented Industries & Keywords
Industries:
Biotechnology
Oil & Gas Midstream
Keywords:
Biopharmaceutical
Life Sciences
Biotechnology
Cancer
Disease
Disorders
Medication
Medicine
Metabolic Disease
Acid
Alcohol
Betashares
Biopharmaceutical Products
Brain Disorders
Cardiomyopathy
Cardiovascular And Metabolic Diseases
Cardiovascular Disease
Chemical Substances
Cholesterol
Clinical Trial
Compare ETFs
